Bioporto | (ABS 030-06-02)货号查询 Pancreatic Polypeptide (human, PP)
如果您对该产品感兴趣的话,可以
产品名称: Bioporto | (ABS 030-06-02)货号查询 Pancreatic Polypeptide (human, PP)
产品型号: 200µl
产品展商: BioPorto Diagnostics A/S
产品文档: 无相关文档
简单介绍
Bioporto | Bioporto | (ABS 030-06-02)货号查询 Pancreatic Polypeptide (human, PP)
Bioporto 400-968-7988 Pancreatic Polypeptide (human, PP)
请认准上海拜力生物科技有限公司为Bioporto品牌的签约代理!Bioporto | (ABS 030-06-02)货号查询其他产品信息,http://www.bioleaf.com/Brand_3653182_1.html
Bioporto | (ABS 030-06-02)货号查询 Pancreatic Polypeptide (human, PP)
的详细介绍
Bioporto 400-968-7988
Bioporto | (ABS 030-06-02)货号查询 Pancreatic Polypeptide (human, PP)
Bioporto 400-968-7988 Pancreatic Polypeptide (human, PP)
请认准上海拜力生物科技有限公司为Bioporto品牌的签约代理!Bioporto | (ABS 030-06-02)货号查询其他产品信息,http://www.bioleaf.com/Brand_3653182_1.html
NOW AVAILABLE: THE NGAL TEST FOR SIEMENS BN SYSTEMS
May 2017
NEW MARKET REPORT FROM FUTURE MARKET INSIGHTS
December 2016
NEW ANTIBODIES LAUNCHED
April 2016
LAUNCH OF NEW ANTIBODIES
December 2015
Bioporto | (ABS 030-06-02)货号查询
Bioporto 400-968-7988
请认准上海拜力生物科技有限公司为Bioporto品牌的签约代理!Bioporto | (ABS 030-06-02)货号查询其他产品信息,http://www.bioleaf.com/Brand_3653182_1.html
CSA-NGAL SCORE
SCIENTIFIC ADVISORY BOARD
Cardiac surgery-associated acute kidney injury (CSA-AKI):
Discussion Cardiac surgery-associated NGAL (CSA-NGAL) score
BioPorto is proud to announce that the paper "The cardiac surgery-associated NGAL score: a potential tool to monitor acute tubular damage" authored by our esteemed Scientific Advisory Board chaired by Prof. Dr. med Jean-Louis Vincent have been accepted in The Journal of Thoracic and Cardiovascular Surgery.
Download paper here.
BioPorto Scientific Advisory Board members are
-
Prof. Dr. med Jean-Louis Vincent, Erasme, Belgium. (Chair)
-
Assoc. Prof. Dr. med Andrew Lewington, St. James’s University Hospital, Leeds, UK.
-
Director Dr. med Claudio Ronco, San Bortolo Hospital, Vicenza, Italy
-
Prof. Dr. med Laurent Jacob, Saint-Louis Hospital, Paris, France
-
Prof. Dr. med Michael Haase, Otto-von Guericke University, Magdeburg, Germany
-
Dr. med, PhD, Hilde RH de Geus, Eramus University Medical Center Rotterdam, NL
Important recognition of NGAL as a potential tool to monitor acute tubular damage
While a large number of scientific articles documenting NGAL’s use as a marker for the detection of acute kidney injury have been published, the Advisory Board’s white paper is the first article suggesting guidelines based on reported clinical use of NGAL for the intervention and patient management both before and after the operation based on measurements of NGAL.
For the first time, the article equips the clinical staff at the cardiac intensive care unit with a decision algorithm for the practical application of NGAL. BioPorto expects that the article will be given weight in the decision-making processes that lead to the inclusion of NGAL tests in official clinical guidelines, which in several countries are determined at a national level.
Peter M?rch Eriksen, CEO of BioPorto, said: "The Journal of Thoracic and Cardiovascular Surgery publishing the Advisory Board’s white paper is an important recognition of NGAL and a strategic milestone for BioPorto. I am convinced that the article with the suggested guidelines will open doors for NGAL-based tests worldwide and contribute to faster and improved renal injury diagnostics for the benefit of patients and clinicians."
BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the NASDAQ OMX: BIOPOR Copenhagen stock exchange.
Bioporto | (ABS 030-06-02)货号查询
Bioporto 400-968-7988
请认准上海拜力生物科技有限公司为Bioporto品牌的签约代理!Bioporto | (ABS 030-06-02)货号查询其他产品信息,http://www.bioleaf.com/Brand_3653182_1.html
BUY ONLINE
The NGAL Test – first diagnostic acute kidney injury biomarker which can be measured in both human urine and plasma. NGAL measurements are useful in the diagnosis of acute kidney injury which may lead to acute renal failure.
The NGAL Test is not available in the USA for in vitro diagnostic use.
We have also launched a unique range of NGAL human an animal antibodies and ELISA kits for research on nephrotoxity.
BUY ONLINE
Enter our world of high quality monoclonal antibodies and immunoassays. We offer highly specific antibodies for pharmaceutical research and in vitro diagnostic test. Antibodies from BioPorto Diagnostics are in several cases highly cited under the Antibodyshop brand.
We have unique antibodies in areas such as diabetes and obesity, allergy and immune deficiency.
BUY ONLINE
With the new gRAd OneDetection Kit YOU have all needed to speed up your research and develop your own custom lateral flow assays.
Developing your own customized lateral flow assay has now become easier and faster with the gRAD OneDetection Kit. Using BioPorto Diagnostics' gRAD One Detection Kit, you will be able to develop a new test in just a couple of weeks.